Core Insights - Cross Country Healthcare (CCRN) reported a revenue of 339.77millionforthequarterendedJune2024,reflectingayear−over−yeardeclineof37.20.10 compared to 0.69ayearago[1]−ThereportedrevenueexceededtheZacksConsensusEstimateof334.33 million by 1.63%, while the EPS fell short of the consensus estimate of 0.14by28.57291.45 million, which is a 41.2% decrease year-over-year, but above the average estimate of 284.91million[6]−Physicianstaffingrevenuewasreportedat48.32 million, slightly above the estimated 48.15million,markinga6.61,992, higher than the average estimate of 1,894[3]−AveragerevenueperFTEperdayfornurseandalliedstaffingwas377, slightly below the average estimate of $387.50 [4] Stock Performance - Over the past month, shares of Cross Country have returned 32.2%, contrasting with the Zacks S&P 500 composite's decline of 0.4% [6] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [6]